Evidence map›Paper›PMID 23589567›Full record

ArticleThe Journal of experimental medicine2013

The link between antibodies to OxLDL and natural protection against pneumococci depends on D(H) gene conservation.

Andre M Vale, Pratibha Kapoor, Greg A Skibinski, Ada Elgavish, Tamer I Mahmoud, Cosima Zemlin, Michael Zemlin, Peter D Burrows, Alberto Nobrega, John F Kearney and 2 more

Abstract read
In one paragraph

Article in The Journal of experimental medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Noncanonical B Cells: Characteristics of Uncharacteristic B Cells.Journal of immunology (Baltimore, Md. : 1950) · 2023
    Review
  3. Article
  4. Article
  5. Development of a Prognostic Nomogram for Acute Myeloid Leukemia onInternational journal of general medicine · 2021
    Article
  6. Replacement of TCR Dβ With Immunoglobulin DFrontiers in immunology · 2020
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Defining Natural Antibodies.Frontiers in immunology · 2017
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Andre M ValeDepartment of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Pratibha Kapoor
Greg A Skibinski
Ada Elgavish
Tamer I Mahmoud
Cosima Zemlin
Michael Zemlin
Peter D Burrows
Alberto Nobrega
John F Kearney
David E Briles
Harry W Schroeder

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Robert S Welner · 1985 to 2026
$165.9M
IMMUNOLOGIC DISEASES AND BASIC IMMUNOLOGYT32AI007051 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Laurie Ellen Harrington · 1985 to 2026
$13.1M
ROS Modulation of Innate and Adaptive Immunity in RAP30AR048311 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MOUNTZ, JOHN D · 2001 to 2017
$9.5M
Regulation of B cell Clonal Diversity and Its Role in DiseaseR01AI014782 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KEARNEY, JOHN FRANKLIN · 1985 to 2020
$7.1M
The role of Immunoglobulin CDRH3 in Autoimmune DiseaseR01AI048115 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SCHROEDER, HARRY WILLIAM · 2000 to 2010
$3.1M
Role of IG CDR-H3 in Responses to HIV VaccinesR01AI090742 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SCHROEDER, HARRY WILLIAM · 2010 to 2013
$1.5M
Role of immunoglobulin CDR-H3 in heterosubtypic immunity to influenza virusR21AI088498 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SCHROEDER, HARRY WILLIAM · 2010 to 2011
$401k
The Role of Immunoglobulin CDRH3 in Autoimmune DiseaseR56AI048115 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SCHROEDER, HARRY WILLIAM · 2012 to 2012
$366k
REGULATION OF B CELL CLONAL DIVERSITYR21AI014782 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KEARNEY, JOHN FRANKLIN · 2000 to 2000
$179k
Defining the interaction of FCRLA with immunoglobulinR03AI100076 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BURROWS, PETER DANIEL · 2012 to 2013
$147k
NCI NIH HHS P30 CA013148NIAID NIH HHS AI021458NIAID NIH HHS AI088498NIAID NIH HHS AI090742NIAID NIH HHS AI100076-01NIAID NIH HHS AI14782NIAID NIH HHS NIH-AI048115NIAID NIH HHS R01 AI014782NIAID NIH HHS R01 AI048115NIAID NIH HHS R01 AI090742NIAID NIH HHS R03 AI100076NIAID NIH HHS R21 AI014782NIAID NIH HHS R21 AI088498NIAID NIH HHS R56 AI048115NIAID NIH HHS T32 AI007051NIAMS NIH HHS P30 AR048311
6 · The paper itself

Abstract

Selection and physiological production of protective natural antibodies (NAbs) have been associated with exposure to endogenous antigens. The extent to which this association depends on germline NAb sequence is uncertain. Here we show that alterations in germline D(H) sequence can sever the association between the production of self-reactive NAbs and NAbs that afford protection against a pathogen. In unmanipulated hosts, the availability of the evolutionarily conserved DFL16.1 gene segment sequence profoundly affected the serum levels of NAbs against bacterial phosphorylcholine but not oxidized low-density lipoprotein. Mice with partially altered DFL16.1 sequence could use N nucleotides to recreate the amino acid sequence associated with the classical protective T15 idiotype–positive NAbs, whereas those without DFL16.1 could not. DFL16.1 gene-deficient mice proved more susceptible to challenge with live Streptococcus pneumoniae. Our findings indicate that although production of self-reactive NAbs can be independent of germline D(H) sequence, their capacity to provide protection against pathogens cannot. The potential relevance of these findings for the rational design of vaccines is discussed.

Indexed as

Amino Acid SequenceAnimalsAntibodiesAntibody FormationComplementarity Determining RegionsConserved SequenceCross ReactionsEvolution, MolecularFrameshift MutationGenetic LociGerm CellsImmunizationImmunoglobulin Heavy ChainsLipoproteins, LDLMiceMice, Inbred BALB CAntibodiesComplementarity Determining RegionsImmunoglobulin Heavy ChainsLipoproteins, LDLoxidized low density lipoproteinPhosphorylcholineRNA, Messenger

Identifiers

PMID23589567
PMCPMC3646500

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.